Industry Expert in Drug and Alcohol Testing — Business Business for Sale in TX
Industry Expert in Drug and Alcohol Testing is a business business listed for sale at $510K in TX. The business generates $116K in annual cash flow on $831K in revenue..
Key Financial Metrics
Asking price: $510K. Cash flow: $116K. Revenue: $831K. Multiple: N/A. Grade: C.
What is the asking price for this business business?
This business business in TX is listed at $510K. It generates $116K in annual seller's discretionary earnings (SDE).
How is a business business typically valued?
Business businesses are most commonly valued using a multiple of seller's discretionary earnings (SDE), typically ranging from 2.5x to 4x depending on factors like revenue size, customer concentration, owner dependency, growth trajectory, and the quality of financial records. Businesses with recurring revenue, strong management teams, and diversified customer bases command multiples at the higher end. Dealright's AI advisor can help you evaluate this specific listing using practitioner-level M&A methodology.
What should I look for when evaluating a business business for acquisition?
Key evaluation criteria for business businesses include: (1) Customer concentration — what percentage of revenue comes from the top 3-5 clients, (2) Owner dependency — how many hours does the current owner work and what functions only they can perform, (3) Revenue quality — what portion is recurring vs. project-based, (4) Team stability — key employee tenure and whether the business operates without the owner present, (5) Financial documentation — are there clean books, tax returns, and bank statements that support reported earnings. Dealright's AI advisor is trained on 19,000+ M&A practitioner entries and can walk you through a complete evaluation for free.
Analyze This Deal on Dealright
Dealright is a free AI-powered M&A advisory platform with 13844+ business listings, financial modeling tools, SBA loan qualification, and an AI advisor trained on 19,000+ practitioner knowledge entries. Sign up free to analyze this deal, build your acquisition pipeline, and connect with M&A professionals.